Alzheimer’s remains one of the most devastating diseases in the world, and though there are more than 44 million people with it worldwide, there are still...
The Context: Amyotrophic lateral sclerosis (ALS) affects motor neurons, the cells that send signals to our muscles, gradually paralyzing patients. Scientists know that a mutation in...
The Context: Studying brain development can be difficult since scientists cannot easily access developing brain tissue. Creating models of human brain development from stem cells allows...
The Context: We’ve all heard that stress can turn your hair gray. But there hasn’t been much scientific evidence that this is true — and if...
We are delighted to share that NYSCF CEO Susan L. Solomon will receive the 2020 Public Service Award from the International Society for Stem Cell Research...
The Context: Age-related macular degeneration (AMD) results from the death of retinal pigmented epithelial cells (RPEs) in the eye. Bruch’s membrane is a structure that sits...
Research teams will use stem cell and gene editing technologies to advance NK cell-based therapies for cancer New York, New York (January 9, 2020) – The...
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
When Ariya Panwala was born, she was a happy, squirmy baby — but after a few months, her parents noticed she wasn’t advancing as expected. Her...
The Context: NRXN1 is a gene that is broadly implicated in neuropsychiatric disorders such as schizophrenia, autism spectrum disorder, and epilepsy; however, the ways in which...
The Context: Alcohol use disorders affect roughly 15 million Americans, but why some people are more susceptible to compulsive drinking than others is not well understood....
The Context: After a bone graft is created from stem cells, it will likely have to be preserved for a while before it reaches a patient....
Brain cells derived from the stem cells of multiple sclerosis and Parkinson’s disease patients are on their way up to the International Space Station! This afternoon,...
Cancer patients can often feel powerless. They want to do all they can, but many feel as though they don’t have much control over their treatment....
First patient-derived, induced pluripotent stem cell disease-specific organoid models in microgravity to advance understanding of neurodegenerative disease LOUISVILLE, KY — (BUSINESS WIRE) — The National Stem...
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
A new collaboration between the NYSCF Research Institute, Johns Hopkins University School of Medicine (JHUSOM), and Bloomberg Philanthropies is aiming to push precision medicine forward using...
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches New York, NY (October 22, 2019) –...
New York, NY (October 22, 2019) – The New York Stem Cell Foundation (NYSCF) today announced the 2019 class of NYSCF – Robertson Investigators, welcoming six...
The New York Stem Cell Foundation’s (NYSCF) 14th Annual Conference convenes global leaders in stem cell research to present their latest progress towards new treatments and...
The Context: Pelizaeus – Merzbacher disease (PMD) is a rare neurological condition typically diagnosed in infancy which often becomes fatal by a patient’s teenage years. While...
The Context: Organoids (3D aggregates of human tissue made from stem cells) are advantageous for studying disease and development since they recapitulate the way different cell...
NYSCF – Robertson Neuroscience Investigator Alumna and Gabrielle H. Reem and Herbert J. Kayden Associate Professor Vanessa Ruta, PhD, of The Rockefeller University has been named...
The Context: Schizophrenia has a strong genetic component. Scientists have discovered many genetic variants that may play a role in its onset, but each individual variant...
